Photoelectrochemical water splitting directly converts solar energy to chemical energy stored in hydrogen, a high energy density fuel. Although water splitting using semiconductor photoelectrodes has been studied for more than 40 years, it has only recently been demonstrated using dye-sensitized electrodes. The quantum yield for water splitting in these dye-based systems has, so far, been very low because the charge recombination reaction is faster than the catalytic four-electron oxidation of water to oxygen. We show here that the quantum yield is more than doubled by incorporating an electron transfer mediator that is mimetic of the tyrosine-histidine mediator in Photosystem II. The mediator molecule is covalently bound to the water oxidation catalyst, a colloidal iridium oxide particle, and is coadsorbed onto a porous titanium dioxide electrode with a Ruthenium polypyridyl sensitizer. As in the natural photosynthetic system, this molecule mediates electron transfer between a relatively slow metal oxide catalyst that oxidizes water on the millisecond timescale and a dye molecule that is oxidized in a fast light-induced electron transfer reaction. The presence of the mediator molecule in the system results in photoelectrochemical water splitting with an internal quantum efficiency of approximately 2.3% using blue light.artificial photosynthesis | photoelectrochemistry T he design of biomimetic systems for artificial photosynthesis is of fundamental interest in the study of light-driven electron and proton transfer reactions. It also represents a potential route to the efficient conversion of solar energy to energy stored in fuel. System modeling has shown that it should be possible, using complementary dye molecules that absorb in the infrared and the visible, to construct artificial Z-schemes that split water with over 10% energy conversion efficiency (1, 2). It is simpler in many ways to design small molecules with the proper photoredox properties than it is to find a set of semiconductors that can be coupled for visible light water splitting. Nevertheless, the molecular approach has so far lagged behind the semiconductor-based approach where high efficiencies have been realized with expensive materials (3-7).A ubiquitous problem in molecular artificial photosynthesis is back electron transfer, which rapidly thermalizes the energy stored by light-induced charge separation in donor-acceptor pairs. Recently, our group and several others have studied this problem in dye-sensitized solar cells where a molecular dye and a porous TiO 2 electrode act as the donor-acceptor dyad (8-13). The dye is covalently coupled to a colloidal or molecular water oxidation catalyst. Fast back electron transfer, relative to the rate of water oxidation, results in low quantum yields for water splitting in these systems.It is well known that charge-separation lifetimes in molecular donor-acceptor systems can be increased dramatically by adding secondary electron donors or acceptors to form triads, tetrads, and more complex supermolecu...
Graphical Abstract Highlights d Hi-C analysis of meiotic chromatin architecture during spermatogenesis d TADs and compartments A and B dissolve and then reappear during spermatogenesis d Pachytene chromatin has highly refined transcriptioncorrelated compartments d Inactive X chromosome during MSCI shows unique chromatin architecture
Summary Gene-editing technologies have made it feasible to create nonhuman primate models for human genetic disorders. Here, we report detailed genotypes and phenotypes of TALEN-edited MECP2 mutant cynomolgus monkeys serving as a model for a neurodevelopmental disorder, Rett syndrome (RTT), which is caused by loss-of-function mutations in the human MECP2 gene. Male mutant monkeys were embryonic lethal, reiterating that RTT is a disease of females. Through a battery of behavioral analyses, including primate-unique eye-tracking tests, in combination with brain imaging via MRI, we found a series of physiological, behavioral, and structural abnormalities resembling clinical manifestations of RTT. Moreover, blood transcriptome profiling revealed that mutant monkeys resembled RTT patients in immune gene dysregulation. Taken together, the stark similarity in phenotype and/or endophenotype between monkeys and patients suggested that gene-edited RTT founder monkeys would be of value for disease mechanistic studies as well as development of potential therapeutic interventions for RTT.
Maternal separation (MS), which can lead to hypothalamic pituitary adrenal axis dysfunction and behavioral abnormalities in rhesus monkeys, is frequently used to model early adversity. Whether this deleterious effect on monkeys is reversible by later experience is unknown. In this study, we assessed the basal hair cortisol in rhesus monkeys after 1.5 and 3 y of normal social life following an early separation. These results showed that peer-reared monkeys had significantly lower basal hair cortisol levels than the mother-reared monkeys at both years examined. The plasma cortisol was assessed in the monkeys after 1.5 y of normal social life, and the results indicated that the peak in the peer-reared cortisol response to acute stressors was substantially delayed. In addition, after 3 y of normal social life, abnormal behavioral patterns were identified in the peer-reared monkeys. They showed decreases in locomotion and initiated sitting together, as well as increases in stereotypical behaviors compared with the mother-reared monkeys. These results demonstrate that the deleterious effects of MS on rhesus monkeys cannot be compensated by a later normal social life, suggesting that the effects of MS are long-lasting and that the maternal-separated rhesus monkeys are a good animal model to study early adversity and to investigate the development of psychiatric disorders induced by exposure to early adversity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.